Peerschke E I
Proc Soc Exp Biol Med. 1985 Jun;179(2):232-9. doi: 10.3181/00379727-179-42092.
Calcium is a cofactor of human platelet aggregation. Moreover a direct correlation between the ability of platelets to bind this divalent cation and to aggregate has been demonstrated. Since magnesium can substitute for calcium in supporting aggregation, especially in the presence of low calcium concentrations, and platelet aggregation is inhibited at low pH, the present study was designed to examine the effects of magnesium and low pH on 45calcium binding to human platelets, and to determine whether such effects might be associated with calcium binding to glycoproteins I (GPI) or IIb/IIIa (GPIIb/IIIa), the putative fibrinogen receptor. 45Calcium binding to aspirin-treated platelets that had been depleted of surface-associated calcium by brief exposure to EDTA was evaluated. Magnesium (5-10 mM) or a change in hydrogen ion concentration to decrease the pH from 7.5 to 6.0 was found to inhibit the binding of 45calcium to platelets from healthy donors by 34 +/- 6 and 32 +/- 8% (mean +/- SD, n = 13), respectively. Similar results were obtained with platelets incubated with chymotrypsin to selectively remove GPI or platelets from a patient with the Bernard Soulier Syndrome, congenitally deficient in GPI. In contrast, calcium binding to platelets from two patients with thrombasthenia, lacking GPIIb/IIIa, was reduced 49 +/- 6% and 42 +/- 8% (n = 4) by magnesium and hydrogen ions, respectively. This apparently increased inhibition was attributed to the combined effects of an overall decrease (approximately 50%) in calcium binding to thrombasthenic platelets compared with that in control platelets, and a similar absolute reduction in calcium binding in the presence of magnesium and/or hydrogen ions. No additional inhibition of 45calcium binding was noted in the presence of magnesium and at low pH, indicating that magnesium and hydrogen ions may affect the same platelet membrane binding sites. The data suggest that although modulation of platelet aggregation by magnesium and pH is accompanied by changes in platelet-associated calcium, calcium binding to the three major platelet membrane glycoproteins, GPI, IIb, and IIIa is unaffected.
钙是人体血小板聚集的辅助因子。此外,血小板结合这种二价阳离子的能力与聚集能力之间已被证明存在直接相关性。由于镁在支持聚集方面可替代钙,尤其是在低钙浓度情况下,并且血小板聚集在低pH值时受到抑制,因此本研究旨在检测镁和低pH值对45钙结合人血小板的影响,并确定这些影响是否可能与钙结合到假定的纤维蛋白原受体糖蛋白I(GPI)或IIb/IIIa(GPIIb/IIIa)有关。评估了45钙与经阿司匹林处理且通过短暂暴露于EDTA而耗尽表面相关钙的血小板的结合情况。发现镁(5 - 10 mM)或氢离子浓度变化使pH值从7.5降至6.0分别抑制健康供体血小板对45钙的结合34±6%和32±8%(平均值±标准差,n = 13)。用胰凝乳蛋白酶孵育以选择性去除GPI的血小板或取自一名先天性缺乏GPI的伯纳德·索利尔综合征患者的血小板也得到了类似结果。相比之下,来自两名缺乏GPIIb/IIIa的血小板无力症患者的血小板,镁和氢离子分别使其钙结合减少49±6%和42±8%(n = 4)。这种明显增强的抑制作用归因于与对照血小板相比,血小板无力症血小板的钙结合总体下降(约50%)以及在存在镁和/或氢离子时钙结合的类似绝对减少的综合作用。在存在镁和低pH值的情况下未观察到对45钙结合的额外抑制,表明镁和氢离子可能影响相同的血小板膜结合位点。数据表明,尽管镁和pH值对血小板聚集的调节伴随着血小板相关钙的变化,但钙与三种主要血小板膜糖蛋白GPI、IIb和IIIa的结合未受影响。